Frank E. Thomas - 04 Oct 2022 Form 4 Insider Report for Orchard Therapeutics plc

Reporting relationship: Title: President & Chief Operating Officer
Issuer ticker: N/A
Reported as of: 04 Oct 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Oct 2022, 18:11:15 UTC
Prior SEC filing: 19 Sep 2022
Next SEC filing: 13 Feb 2023
Source filing: View source filing
Reporting owner signature: /s/ Frank E. Thomas

Key filing fact

Frank E. Thomas filed Form 4 for Orchard Therapeutics plc on 06 Oct 2022.

Key facts

This page summarizes Frank E. Thomas's Form 4 filing for Orchard Therapeutics plc.
16 reported transactions and 16 derivative rows are listed below.
Accepted by SEC: 06 Oct 2022, 18:11.

Change

Previous filing in this sequence was filed on 19 Sep 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ORTX transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value: $0
Shares: -426,185
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 04 Oct 2022
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 426,185
Exercise price: $2.44
Footnotes: F1, F2, F3

ORTX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +426,185
Change %
Price: $0.000000
Shares after: 426,185
Date: 04 Oct 2022
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 426,185
Exercise price: $0.5800
Footnotes: F1, F2, F3

ORTX transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value: $0
Shares: -184,229
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 04 Oct 2022
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 184,229
Exercise price: $9.06
Footnotes: F1, F2, F3

ORTX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +184,229
Change %
Price: $0.000000
Shares after: 184,229
Date: 04 Oct 2022
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 184,229
Exercise price: $0.5800
Footnotes: F1, F2, F3

ORTX transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value: $0
Shares: -100,000
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 04 Oct 2022
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 100,000
Exercise price: $12.54
Footnotes: F1, F3, F4

ORTX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +100,000
Change %
Price: $0.000000
Shares after: 100,000
Date: 04 Oct 2022
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 100,000
Exercise price: $0.5800
Footnotes: F1, F3, F4

ORTX transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value: $0
Shares: -200,000
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 04 Oct 2022
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 200,000
Exercise price: $13.58
Footnotes: F1, F3, F5

ORTX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +200,000
Change %
Price: $0.000000
Shares after: 200,000
Date: 04 Oct 2022
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 200,000
Exercise price: $0.5800
Footnotes: F1, F3, F5

ORTX transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value: $0
Shares: -150,000
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 04 Oct 2022
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 150,000
Exercise price: $7.05
Footnotes: F1, F3, F6

ORTX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +150,000
Change %
Price: $0.000000
Shares after: 150,000
Date: 04 Oct 2022
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 150,000
Exercise price: $0.5800
Footnotes: F1, F3, F6

ORTX transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value: $0
Shares: -310,000
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 04 Oct 2022
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 310,000
Exercise price: $5.98
Footnotes: F1, F3, F7

ORTX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +310,000
Change %
Price: $0.000000
Shares after: 310,000
Date: 04 Oct 2022
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 310,000
Exercise price: $0.5800
Footnotes: F1, F3, F7

ORTX transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value: $0
Shares: -27,731
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 04 Oct 2022
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 27,731
Exercise price: $5.98
Footnotes: F1, F2, F3

ORTX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +27,731
Change %
Price: $0.000000
Shares after: 27,731
Date: 04 Oct 2022
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 27,731
Exercise price: $0.5800
Footnotes: F1, F2, F3

ORTX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +457,811
Change %
Price: $0.000000
Shares after: 457,811
Date: 04 Oct 2022
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 457,811
Exercise price: $0.5800
Footnotes: F3, F8

ORTX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +75,000
Change %
Price: $0.000000
Shares after: 75,000
Date: 04 Oct 2022
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 75,000
Exercise price: $0.5800
Footnotes: F3, F9

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 9 footnotes

Footnote F1

On October 4, 2022, the Compensation Committee of the Issuer's Board of Directors approved an option repricing. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

Footnote F2

The shares subject to this option are fully vested and exercisable as of the date hereof.

Footnote F3

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Footnote F4

The shares subject to this option vest in equal monthly installments over the four years after January 16, 2019.

Footnote F5

The shares subject to this option vest in equal monthly installments over the four years after January 2, 2020.

Footnote F6

The shares subject to this option vest in equal monthly installments over the four years after April 1, 2020.

Footnote F7

The shares subject to this option vest in equal monthly installments over the four years after February 1, 2021.

Footnote F8

The shares subject to this option vest in equal monthly installments over the three years after October 4, 2022.

Footnote F9

The shares subject to this option vest in equal monthly installments over the two years after July 1, 2024.

SEC remarks

Title: President & Chief Operating Officer